|
Sign In to gain access to subscriptions and/or personal tools.
|
The potential role of nitric oxide in multiple sclerosis
G Giovannoni
Neuroimmunology Unit, Institute of Neurology, Queen Square, London WC1N 3BG
S J.R. Heales
Department of Clinical Biochemistry, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG
J M Land
Department of Clinical Biochemistry, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG
E J Thompson
Department of Neuroimmunology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, Neuroimmunology Unit, Institute of Neurology, Queen Square, London WC1N 3BG
Nitric oxide (.NO) and its reactive derivative peroxynitrite (ONOO7) have been implicated in the pathogenesis of multiple sclerosis (MS). They are cytotoxic to oligodendrocytes and neurones in culture by inhibiting the mitochondrial respiratory chain (complexes II/III and IV) and inhibiting certain key intracellular enzymes. Recently .NO has been implicated as a possible aetiological factor in reversible conduction block in demyelinated axons. Inducible nitric oxide synthase (iNOS) is upregulated in the central nervous system of animals with experimental allergic encephalomyelitis (EAE) and in patients with MS. In some EAE models inhibiting iNOS activity decreases disease severity whilst in other models disease activity is exacerbated. Raised levels of nitrate and nitrite, stable end-products of .NO/ONOO7, are found in the cerebrospinal fluid, serum and urine of patients with MS. CSF levels of nitrate and nitrite correlate with blood-brain-barrier dysfunction, which suggests that .NO may play a role in inflammatory blood-brain-barrier dysfunction. In a longitudinal study on 24 patients with relapsing remitting and secondary progressive MS, raised serum nitrate and nitrite levels correlated with a relapsing course and infrequent relapses. However, no correlation was found between raised serum levels of nitrate and nitrite and MRI activity, disease progression, or the development of cerebral atrophy. In autoimmune mediated CNS demyelinating disease .NO may be a double-edged sword, mediating tissue damage on the one hand and on the other hand modulating complex immunological functions which may be protective.
Key Words: multiple sclerosis nitric oxide nitrate nitrite nitric oxide synthase
Multiple Sclerosis, Vol. 4, No. 3,
212-216 (1998)
DOI: 10.1177/135245859800400323

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev,
January 1, 2007;
87(1):
315 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rozenfeld, R. Martinez, S. Seabra, C. Sant'Anna, J. G. R. Goncalves, M. Bozza, V. Moura-Neto, and W. De Souza
Toxoplasma gondii Prevents Neuron Degeneration by Interferon-{gamma}-Activated Microglia in a Mechanism Involving Inhibition of Inducible Nitric Oxide Synthase and Transforming Growth Factor-{beta}1 Production by Infected Microglia
Am. J. Pathol.,
October 1, 2005;
167(4):
1021 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Paintlia, M. K. Paintlia, M. Khan, T. Vollmer, A. K. Singh, and I. Singh
HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis
FASEB J,
September 1, 2005;
19(11):
1407 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu, C. Ciumas, Y.-M. Huang, K. R Steffensen, H. Lian, H. Link, and B.-G. Xiao
Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis
Multiple Sclerosis,
August 1, 2005;
11(4):
381 - 389.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Baranzini, C. C. A. Bernard, and J. R. Oksenberg
Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis
J. Immunol.,
June 1, 2005;
174(11):
7412 - 7422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rozenfeld, R. Martinez, R. T. Figueiredo, M. T. Bozza, F. R. S. Lima, A. L. Pires, P. M. Silva, A. Bonomo, J. Lannes-Vieira, W. De Souza, et al.
Soluble Factors Released by Toxoplasma gondii-Infected Astrocytes Down-Modulate Nitric Oxide Production by Gamma Interferon-Activated Microglia and Prevent Neuronal Degeneration
Infect. Immun.,
April 1, 2003;
71(4):
2047 - 2057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S.-H. Liu, M.-L. Zhao, C. F. Brosnan, and S. C. Lee
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Am. J. Pathol.,
June 1, 2001;
158(6):
2057 - 2066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao
SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window
J. Immunol.,
May 1, 2001;
166(9):
5810 - 5816.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|